## Core Concept
Waldenström's macroglobulinemia is a type of non-Hodgkin lymphoma characterized by the proliferation of lymphoplasmacytic cells in the bone marrow, leading to an overproduction of IgM monoclonal protein. This condition is associated with various clinical manifestations, including hyperviscosity syndrome, lymphadenopathy, and organomegaly.

## Why the Correct Answer is Right
The correct answer, , is associated with a key characteristic or clinical feature that does not align with Waldenström's macroglobulinemia. Although the specific details of the options are not provided, we can infer that the correct answer relates to an incorrect statement about the disease.

## Why Each Wrong Option is Incorrect
* **Option A:** This option is incorrect because it likely states a true characteristic of Waldenström's macroglobulinemia, such as the presence of IgM monoclonal gammopathy or the involvement of lymphoplasmacytic cells.
* **Option B:** This option is incorrect because it probably describes a common clinical feature or diagnostic criterion for Waldenström's macroglobulinemia, such as bone marrow involvement or the presence of hyperviscosity syndrome.
* **Option C:** This option is incorrect as it may represent another accurate aspect of the disease, like the typical patient population or the association with specific genetic mutations.

## Clinical Pearl / High-Yield Fact
A key point to remember about Waldenström's macroglobulinemia is that it is associated with a specific genetic mutation, the MYD88 L265P mutation, which is present in a significant majority of patients. This mutation can be a helpful diagnostic clue and has implications for targeted therapy.

## Correct Answer: D.